期刊文献+

白细胞介素-14的生物学功能及其与原发性干燥综合征关系的研究进展

The Biological effects of interleukin-14 and its relationship with primary Sj(o)gren's syndrome
原文传递
导出
摘要 白细胞介素(IL)-14又称人高分子B细胞生长因子,主要由滤泡树突状细胞和活化的T细胞产生,并特异性地作用于激活后的B淋巴细胞及恶性B淋巴细胞,使之分化增殖.IL-14不仅是调节B细胞功能的重要细胞因子,其受体也是B细胞上的重要功能分子,并且与某些B细胞性肿瘤和自身免疫性疾病密切相关.IL-14-α由IL-14外显子3-10基因编码.研究表明,原发性和继发性干燥综合征患者表达高水平的IL-14-α,IL-14-α的转基因小鼠更是表现出高丙种球蛋白血症、B细胞性非霍奇金淋巴瘤等干燥综合征典型症状,这提示IL-14在干燥综合征的病理生理学中存在重要意义,对其深入研究或为干燥综合征的发病机制及防治提供理论基础. Interleukin-14(IL-14),also known as human high molecular B-cell growth factor,is produced by the follicular dendritic cells and activated T cells.IL-4 specifically acts on activated B-lymphocytes and malignant B lymphocytes,promoting their differentiation and proliferation.IL-14 is an important cytokine regulating the function of B cell.The receptor,of IL-4 is also an important functional molecule of B cells is related to B-cell tumors and autoimmune diseases.Interleukin-14-alpha (IL-14-α) is a cytokine encoded by the plus strand of the IL-14 gene using exons 3-10.Studies have shown that patients with primary and secondary Sj(o)gren's syndrome express high levels of IL-14-α.Moreover,IL-14-α-transgenic mice demonstrate hypergammaglobulinemia and B-cell Non-Hodgkin' s Lymphoma,which are typical complication of Sj(o)gren' s syndrome.These studies suggest that IL-14 is rather important in the pathophysiology of Sj(o)gren's syndrome.Thoroughly understanding IL-4 might provide basis for the treatment of this disorder.
作者 任杰 安海燕
出处 《国际免疫学杂志》 CAS 2014年第4期324-327,共4页 International Journal of Immunology
基金 广东省中医药局2011年立项课题(20111272) 国家级大学生创新创业训练计划项目(201212121053)
关键词 白细胞介素-14 生物学功能 原发性干燥综合征 Interleukin-14 Biological effects Primary Sj(o)gren's syndrome
  • 相关文献

参考文献33

  • 1Ohtomo N,Tomiya T,Tanoue Y,et al.Expression of α-taxilin in hepatocellular carcinoma correlates with growth activity and malignant potential of the tumor[J].Int J Oncol,2010,37 (6):1417-1423.
  • 2Horii Y,Sakane H,Nogami S,et al.Expression of α-taxilin in the murine gastrointestinal tract:potential implication in cell proliferation[J].Histochem cell biol,2014,141 (2):165-180.
  • 3Horii Y,Nogami S,Kawano Y,et al.Interaction of alpha-taxilin localized on intracellular components with the microtubule cytoskeleton[J].Cell Struct Funct,2012,37 (2):111-126.
  • 4Mashidori T,Shirataki H,Kamai T,et al.Increased alpha-taxilin protein expression is associated with thernetastatic and invasive potential of renal cell cancer[J].Biomed Res,2011,32 (2):103-110.
  • 5Sakakibara S,Nakadate K,Tanaka-NakadateS,et al.Developmental and spatial expression pattern of alpha-taxilin in the rat central nervous system[J].Comp Neurol,2008,511 (1):65-68.
  • 6Shen L,Zhang C,Wang T,et al.Development of autoimmunity in IL-14 transgenic mice[J].Immunol,2006,177 (8):5676-5686.
  • 7Treanor B.B-cell receptor:from resting state to activate[J].Immunology,2012,136(1):21-27.
  • 8Leca N,Laftavi M,Shen L,et al.Regulation of human interleukin 14 transcription in vitro and in vivo after renal transplantation[J].Transplantation,2008,86(2):336-34-1.
  • 9何春华,邹霓.IL-7及其受体与干燥综合征关系的研究进展[J].国际免疫学杂志,2013,36(5):392-396. 被引量:3
  • 10张清平,陈国阳.干燥综合征唇腺催乳素、热休克蛋白70与局部炎症反应的关系[J].国际免疫学杂志,2013,36(6):455-457. 被引量:1

二级参考文献43

  • 1贾园,刘栩,刘传慧,栗占国.系统性红斑狼疮合并干燥综合征患者的临床及实验室特征分析[J].中华风湿病学杂志,2006,10(1):23-26. 被引量:7
  • 2陈小青,林玲,黄子扬,吴春林,郑德源.干燥综合征患者唇腺催乳素表达与局部免疫紊乱[J].中华内科杂志,2006,45(4):323-324. 被引量:7
  • 3Heaton JM.Sj(o)gren's syndrome and systemic lupus erythematosus[J].Br Med J,1959,1:466-469.
  • 4Nossent JC,Swaak AJ.Systemic lupus erythematosus VII:frequency and impact of secondary Sj(o)gren's syndrome[J].Lupus,1998,7:231-234.
  • 5Manoussakis MN,Georgopoulou C,Zintzaras E,et al.Sj(o)gren's syndrome associated with systemic lupus erythematosus:clinical and laboratory profiles and comparison with primary Sj(o)gren's syndrome[J].Arthritis Rheum,2004,50:882-891.
  • 6Pan HF,Ye DQ,Wang Q,et al.Clinical and laboratory profiles of systemic lupus erythematosus associated with Sj(o)gren's syndrome in China:a study of 542 patients[J].Clin Rheumatol,2008,27:339-343.
  • 7Xu D,Tian X,Zhang W,et al.Sj(o)gren's syndrome-onset lupus patients have distinctive clinical manifestations and benign prognosis:a case-control study[J].Lupus,2010,19:197-200.
  • 8Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40:1725.
  • 9Vitali C,Bombardieri S,Jonsson R,et al.Classication criteria of Sjogren's syndrome:a revised version of the European criteria proposed by the American European Consensus Group[J].Ann Rheum Dis,2002,61:554-558.
  • 10Yao Q,Altman RD,Wang X.Systemic lupus erythematosus with Sj(o)gren syndrome compared to systemic lupuserythematosus alone:a meta-analysis[J].J Clin Rheumatol,2012,18:28-32.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部